About
EtiraRX is a biotechnology company committed to transforming the lives of patients with untreatable, therapy-resistant cancers. With a mission that goes beyond remission, EtiraRX develops innovative therapies designed to overcome tumor heterogeneity—the major barrier to effective cancer treatment. By addressing this critical challenge, EtiraRX is pioneering new hope for patients who currently have limited or no therapeutic options.